Viking Therapeutics (VKTX) Q1 2026 Earnings

Feb 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.38
-1.03
-0.68
-0.33

Details

Expected EPS
-0.890244
Actual EPS
-1.38
Surprise EPS
-0.49
Surprise Percent
-55.01%

Description

⁨Viking Therapeutics⁩ (⁦VKTX⁩) has reported earnings of ⁦-1.38⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts